Better together? AbbVie’s Humira and Pfizer’s Lyrica again outspend other brands

AbbVie and Pfizer are becoming an item at the top of the pharma spending charts in 2018. For the fourth month in a row, drugs Humira and Lyrica are No. 1 and No. 2 on the list for TV ad spending, according to data from real time TV ad tracker iSpot.tv.